New drug combo aims to stop bile duct cancer from coming back
Disease control
Not yet recruiting
This study tests whether a combination of two drugs, adebrelimab and S-1, can help prevent bile duct cancer from returning after surgery. About 40 adults who had their cancer completely removed will receive the treatment for several months. Researchers will track how many stay ca…
Phase: PHASE2 • Sponsor: Xingjun Guo • Aim: Disease control
Last updated May 07, 2026 18:42 UTC